Related Experiment Video
Updated: Jul 16, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Danger fuels immune escape
Massimo Russo1, Santiago Zelenay2
1Cancer Inflammation and Immunity, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Abstract:
Extracellular ATP (eATP) is an immunogenic danger signal. In this issue of Immunity, Hu et al. report that in the tumor microenvironment, eATP signals through the receptor P2RY2 on cancer cells, triggering the COX-PGE2 pathway and thereby immune suppression and immunotherapy resistance. These findings identify eATP as the upstream signal driving PGE2 expression, with therapeutic implications.
Insights
Extracellular ATP (eATP) acts as a danger signal in tumors. It activates cancer cell receptor P2RY2, leading to immune suppression and resistance to immunotherapy via the COX-PGE2 pathway.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Signaling
Background:
- Extracellular ATP (eATP) is recognized as a danger signal that modulates immune responses.
- The tumor microenvironment harbors complex signaling networks that influence cancer progression and immune evasion.
Purpose of the Study:
- To elucidate the role of extracellular ATP (eATP) in mediating immune suppression within the tumor microenvironment.
- To identify the specific receptor and downstream pathway through which eATP exerts its effects on cancer cells and immune cells.
Main Methods:
- Analysis of signaling pathways in cancer cells.
- Investigation of receptor-ligand interactions.
- Assessment of immune cell function in the presence of eATP and its downstream mediators.
Main Results:
- Extracellular ATP (eATP) signals through the P2RY2 receptor on cancer cells.
- Activation of P2RY2 triggers the cyclooxygenase-prostaglandin E2 (COX-PGE2) pathway.
- This pathway results in immune suppression and resistance to immunotherapy.
Conclusions:
- eATP is identified as a key upstream signal driving prostaglandin E2 (PGE2) expression in the tumor microenvironment.
- Targeting the eATP-P2RY2-COX-PGE2 axis presents a potential therapeutic strategy to overcome immune suppression and enhance immunotherapy efficacy.
More Related Videos
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Treatment Resistant Cancers
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Tumor Immunotherapy
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

